VSE’s $2 Billion Investment in Precision Aviation Signals a New Era in the Aviation Aftermarket

VSE Corporation’s agreement to acquire Precision Aviation Group (PAG) for approximately $2.025 billion marks a transformational moment—not just for the company, but for the broader aviation aftermarket industry. The deal positions VSE as a scaled, pure-play aviation aftermarket leader with global reach, expanded technical capabilities, and a clearer path to sustained margin expansion.

Under the terms of the agreement, VSE will acquire PAG from GenNx360 Capital Partners for $1.75 billion in cash and roughly $275 million in equity, with the potential for an additional $125 million earnout tied to PAG’s 2026 performance. Including expected synergies, the transaction values PAG at about 13.5x expected 2025 adjusted EBITDA—an assertive but strategic multiple in a high-margin, mission-critical segment.

Founded in 1996 and headquartered in Atlanta, PAG has built a best-in-class platform across aviation maintenance, repair, and overhaul (MRO), parts distribution, and proprietary repair solutions. With 29 locations worldwide, over 1,000 employees, and more than 175,000 repairs completed annually, PAG serves commercial aviation, business and general aviation, rotorcraft, and defense customers. PAG expects to generate approximately $615 million in adjusted revenue in 2025.

The strategic logic is clear. By combining PAG with VSE’s existing aviation operations, the company expects to increase pro forma aviation revenue by roughly 50% in 2025 and significantly deepen its exposure to higher-margin aftermarket services. The combined entity is expected to operate around 60 locations globally, enhancing customer proximity, turnaround times, and aircraft-on-ground support—key differentiators in a sector where reliability and speed are paramount.

Margin expansion is central to the deal thesis. PAG’s adjusted EBITDA margin is expected to be immediately accretive, and VSE believes the combined company can exceed a 20% consolidated adjusted EBITDA margin over the next few years. This improvement is expected to be driven by increased proprietary repair content, operational leverage, procurement efficiencies, and more than $15 million in anticipated annual synergies from cross-selling, insourcing, and network optimization.

Beyond scale, the acquisition meaningfully broadens VSE’s technical capabilities. PAG’s four business units—component services, engine services, avionics, and proprietary solutions—complement VSE’s existing offerings and enhance its ability to extend asset life and reduce total cost of ownership for customers. This expanded portfolio strengthens VSE’s positioning as a mission-critical partner across multiple aviation end markets, including defense, which adds resilience through economic cycles.

Management commentary underscores the long-term ambition. VSE CEO John Cuomo described the acquisition as a “pivotal moment” in building a differentiated, higher-margin aviation aftermarket platform. PAG CEO David Mast emphasized the cultural and strategic alignment between the two organizations, while GenNx360 signaled confidence through a substantial equity rollover.

Financially, VSE enters the transaction from a position of strength. Preliminary 2025 results point to revenue of approximately $1.1 billion and adjusted EBITDA approaching $180 million, with positive free cash flow for the full year. The cash portion of the deal is supported by a fully committed bridge facility, and the transaction is expected to close in the second quarter of 2026, pending regulatory approvals.

Taken together, the VSE–PAG combination reflects a broader industry trend: consolidation around scaled platforms with proprietary capabilities, predictable cash flows, and high barriers to entry. If executed as planned, this deal could redefine VSE’s growth trajectory—and set a new benchmark for value creation in the aviation aftermarket.

Release – V2X and Amazon to Partner on Smart Warehousing and Global Logistics Automation

V2X (PRNewsfoto/V2X, Inc.)

Research News and Market Data on VVX

January 29, 2026

RESTON, Va., Jan. 29, 2026 /PRNewswire/ — V2X, Inc. (NYSE: VVX) today announced a key strategic partnership with Amazon to deliver smart warehousing and automation technologies to the companies’ mutual U.S. Government customers to support a diverse and global mission set.

V2X will leverage Amazon’s extensive knowledge of warehouse automation, including its advanced computer-vision AI models, across V2X-managed warehouses in adherence with all relevant standards. This partnership will enable unprecedented levels of insight and controls across these ecosystems, while further optimizing the world class efficiency and readiness of V2X programs.

This collaboration expands V2X’s ability to meet the evolving national demands for mission support capabilities, by advancing cutting-edge solutions with safe, secure, and trustworthy AI across critical mission areas, including:

  • Revolutionizing Smart Warehousing Operations: Introducing advanced robotics, computer vision, and AI-driven automation to optimize inventory management, streamline workflows, and enable seamless adaptability to dynamic mission demands.
  • Streamlined Logistics and Operational Sustainment: Deploying predictive analytics and automated workflows to elevate supply chain visibility, reduce downtime, and ensure mission-critical asset availability.
  • AI-Driven Insights to Inform Decision-Making: Harnessing multi-modal data analysis to deliver actionable insights for optimization of supply chain operations, enabling commanders to make informed real-time decisions in both complex and rapidly evolving environments.
  • Resilient and Adaptive Mission Planning and Risk Assessment: Integrating AI-powered risk assessment and proactive resource planning to safeguard supply chain operations against disruptions, ensuring uninterrupted support for global missions.

“V2X continually looks for ways to drive improved operational speed and mission resilience across defense and government environments, and our partnership with Amazon is an example of that work in action for the benefit of the customers we serve,” said Jeremy C. Wensinger, President and Chief Executive Officer at V2X. “V2X has deep expertise in mission integration and global logistics and when strategically combined with Amazon’s smart warehousing technologies and AI applications, we will be able to provide federal agencies with unparalleled system readiness, actionable insight and scalable solutions across their entire supply chain.”

V2X is partnering with top tier technology providers in the areas of AI and smart readiness to advance the Company’s leadership in data-enabled mission solutions across all domains.

Disclaimer

Capabilities described are subject to applicable contractual authorizations and accreditation processes.

About V2X

V2X builds innovative solutions that integrate physical and digital environments by aligning people, actions, and technology. V2X is embedded in all elements of a critical mission’s lifecycle to enhance readiness, optimize resource management, and boost security. The company provides innovation spanning national security, defense, civilian, and international markets. With a global team of approximately 16,000 professionals, V2X enables mission success by injecting right technologies including AI and machine learning capabilities to meet today’s toughest challenges across all operational domains and maintain relevancy for the evolving mission parameters.

Investor Contact
Mike Smith, CFA
Vice President, Treasury, Corporate Development and Investor Relations
IR@goV2X.com
719-637-5773

Media Contact
Angelica Spanos Deoudes
Director, Corporate Communications
Angelica.Deoudes@goV2X.com
571-338-5195

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/v2x-and-amazon-to-partner-on-smart-warehousing-and-global-logistics-automation-302674152.html

SOURCE V2X, Inc.

Release – Federal Court Dismisses All of Remaining Claims Against SEGG Media

Research News and Market Data on SEGG

    January 29, 2026

    PDF Version

    FORT WORTH, Texas, Jan. 29, 2026 (GLOBE NEWSWIRE) — SEGG Media Corporation, formerly Lottery.com Inc., (NASDAQ: SEGG, LTRYW)(the “Company” or “SEGG Media”), the global sports, entertainment, and gaming group continues its transparent and material transformation as it announces today that the United States District Court for the Middle District of Florida (the “Court”) dismissed, without prejudice, the remaining claims in a legacy litigation styled Lottery.com, Inc. f/k/a Autolotto, Inc., et al. v. John J. Brier, Jr., et al., Case No. 8:23-cv-2594 (M.D. Fla.).

    In its January 28, 2026 order, the Court granted, in part, the Company’s renewed motion to dismiss for lack of subject matter jurisdiction and declined to exercise supplemental jurisdiction over the defendants’ remaining state-law counterclaims. The Court overruled all objections made by the defendants to the Magistrate Judge’s findings and directed that the case be closed.

    The Court’s ruling follows the prior dismissal of all federal claims in the action. With no federal claims remaining, the Court determined that it lacked subject matter jurisdiction to adjudicate the remaining state-law claims and dismissed those claims without prejudice, meaning they were not adjudicated on the merits.

    “We are delighted with this outcome and agree with the Court’s decision and its application of well-established jurisdictional principles,” said Gregory Potts, SEGG Media Chief Operating Officer.

    The Company views this ruling as a procedural resolution consistent with established federal jurisdictional principles. With yet another dismissal in legacy litigation matters, the new management team at SEGG Media continues to remain focused on executing its business strategy, further developing its core business assets (Sports.com, Concerts.com, TicketStub.com and Lottery.com), driving revenue growth, completing on cash-generative strategically-targeted acquisitions and creating long-term shareholder value.

    About SEGG Media Corporation
    SEGG Media (Nasdaq: SEGG, LTRYW) is a global sports, entertainment and gaming group operating a portfolio of digital assets including Sports.com, Concerts.com, TicketStub.com and Lottery.com. Focused on immersive fan engagement, ethical gaming and AI-driven live experiences, SEGG Media is redefining how global audiences interact with the content they love.

    Important Notice Regarding Forward-Looking Statements 

    This press release contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of present or historical fact included in this press release, regarding the Company’s strategy, future operations, prospects, plans and objectives of management, are forward-looking statements. When used in this Form 8-K, the words “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” “initiatives,” “continue,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. The forward-looking statements speak only as of the date of this press release or as of the date they are made. The Company cautions you that these forward-looking statements are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company. In addition, the Company cautions you that the forward-looking statements contained in this press release are subject to risks and uncertainties, including but not limited to, any future findings from ongoing review of the Company’s internal accounting controls, additional examination of the preliminary conclusions of such review, the Company’s ability to secure additional capital resources, the Company’s ability to continue as a going concern, the Company’s ability to respond in a timely and satisfactory matter to the inquiries by Nasdaq, the Company’s ability to regain compliance with the Bid Price Requirement, the Company’s ability to regain compliance with Nasdaq Listing Rules, the Company’s ability to become current with its SEC reports, and those additional risks and uncertainties discussed under the heading “Risk Factors” in the Form 10-K/A filed by the Company with the SEC on April 22, 2025, and the other documents filed, or to be filed, by the Company with the SEC. Additional information concerning these and other factors that may impact the operations and projections discussed herein can be found in the reports that the Company has filed and will file from time to time with the SEC. These SEC filings are available publicly on the SEC’s website at www.sec.gov. Should one or more of the risks or uncertainties described in this press release materialize or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. Except as otherwise required by applicable law, the Company disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release.

    This press release was published by a CLEAR® Verified individual.

    For additional information, visit www.seggmediacorp.com or contact media relations at media@seggmediacorp.com

    Release – UPDATE – Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission

    Research News and Market Data on UNCY

    January 29, 2026 9:15am EST Download as PDF

    • FDA assigns Prescription Drug User Fee Act (PDUFA) target date of June 29, 2026
    • Ended 2025 with unaudited cash position of $41.3M with expected runway into 2027

    LOS ALTOS, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the Company’s investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. The Agency has deemed the OLC resubmission to be a Class II complete response which has a six-month review period from the date of resubmission and set a Prescription Drug User Fee Act (PDUFA) target action date of June 29, 2026.

    “We are pleased that the agency has promptly accepted the resubmission of our NDA for OLC,” said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive. “We are advancing our commercial preparation activities in anticipation of a potential launch of OLC later this year, to help provide an important treatment option to patients with chronic kidney disease (CKD) on dialysis who continue to struggle with hyperphosphatemia.”

    The NDA is supported by data from three clinical studies (a Phase 1 study in healthy volunteers, a bioequivalence study in healthy volunteers and a tolerability study of OLC in CKD patients on dialysis), multiple preclinical studies as well as chemistry, manufacturing and controls (CMC) data. The FDA did not raise any concerns regarding OLC’s preclinical, clinical, or safety data included in the original NDA submission.

    The Company ended 2025 with an unaudited position of $41.3 million in cash, cash equivalents, and short-term investments, which permits continued advancement of OLC commercial launch activities and a cash runway into 2027.

    About Oxylanthanum Carbonate (OLC)
    OLC is an investigational oral phosphate binder that leverages proprietary nanoparticle technology to deliver high phosphate binding potency, reducing the number and size of pills that patients must take to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. Its potential best-in-class profile may have meaningful patient adherence benefits over currently available treatment options as it requires a lower pill burden.

    Unicycive is seeking FDA approval of OLC via the 505(b)(2) regulatory pathway. OLC is protected by a strong global patent portfolio including issued patents on composition of matter with exclusivity until 2031, and with the potential for patent term extension until 2035.

    About Hyperphosphatemia
    Hyperphosphatemia is a serious medical condition that occurs in nearly all patients with End Stage Renal Disease (ESRD). Annually there are over 450,000 individuals in the U.S. that require medication to control their phosphate levels.1 Uncontrolled hyperphosphatemia is strongly associated with increased death and hospitalization for CKD patients on dialysis. Treatment of hyperphosphatemia is aimed at lowering serum phosphate levels via two means: (1) restricting dietary phosphorus intake; and (2) using, on a daily basis, and with each meal, oral phosphate binding drugs that facilitate fecal elimination of dietary phosphate rather than its absorption from the gastrointestinal tract into the bloodstream.

    1Flythe JE. Dialysis-Past, Present, and Future: A Kidney360 Perspectives Series. Kidney360. 2023 May 1;4(5):567-568. doi: 10.34067/KID.0000000000000145.

    About Unicycive Therapeutics
    Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. For more information about Unicycive, visit Unicycive.com and follow us on LinkedIn and X.

    Forward-looking statements
    Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified using words such as “anticipate,” “believe,” “forecast,” “estimated” and “intend” or other similar terms or expressions that concern Unicycive’s expectations, strategy, plans or intentions. These forward-looking statements are based on Unicycive’s current expectations and actual results could differ materially. There are several factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, clinical trials involve a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future trial results; our clinical trials may be suspended or discontinued due to unexpected side effects or other safety risks that could preclude approval of our product candidates; risks related to business interruptions, which could seriously harm our financial condition and increase our costs and expenses; our need to raise substantial additional capital in the future to fund our continuing operations and the development and commercialization of our current product candidates and future product candidates; dependence on key personnel; substantial competition; uncertainties of patent protection and litigation; dependence upon third parties; risks related to delays in obtaining or failure to obtain FDA clearances or approvals and noncompliance with FDA regulations; and our failure, or the failure of our third-party manufacturers, or their subcontractors, to comply with cGMPs or other applicable regulations, which could result in sanctions being imposed on us or the manufacturers, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates, operating restrictions and criminal prosecutions, any of which could adversely affect supplies of our product candidates and harm our business and results of operations. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and other factors described more fully in the section entitled ‘Risk Factors’ in Unicycive’s Annual Report on Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Unicycive specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

    Investor Contacts:

    Kevin Gardner
    LifeSci Advisors
    kgardner@lifesciadvisors.com

    Media Contact:

    Layne Litsinger
    Real Chemistry
    llitsinger@realchemistry.com

    SOURCE: Unicycive Therapeutics, Inc.

    Primary Logo

    Source: Unicycive Therapeutics, Inc.

    Released January 29, 2026

    Release – Alliance Entertainment to Host Second Quarter Fiscal Year 2026 Results Conference Call on February 12 at 4:30 p.m. Eastern Time

    Research News and Market Data on AENT

    PLANTATION, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a premier distributor, logistics provider, and omnichannel fulfillment partner to the entertainment and pop culture collectibles industry, supplying more than 340,000 unique SKUs across physical media, video games, toys, licensed merchandise, and exclusive collectibles to over 35,000 retail and e-commerce storefronts, will hold a conference call on Thursday, February 12, at 4:30 p.m. Eastern Time to discuss its results for the second quarter of fiscal year 2026 ended December 31, 2025. A press release detailing these results will be issued prior to the call.

    Alliance Entertainment Chief Executive Officer Jeff Walker, Chief Financial Officer Amanda Gnecco, and Executive Chairman Bruce Ogilvie will host the conference call, which will be followed by a question-and-answer session. A presentation will accompany the call and can be viewed during the webcast or accessed via the investor relations section of the Company’s website here.

    To access the call, please use the following information:

    Date:Thursday, February 12, 2026
    Time:4:30 p.m. Eastern Time, 1:30 p.m. Pacific Time
    Toll-free dial-in number:1-877-407-0784
    International dial-in number:1-201-689-8560
    Conference ID:13758224

    Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact RedChip Companies at 1-407-644-4256.

    The conference call will be broadcast live and available for replay at https://viavid.webcasts.com/starthere.jsp?ei=1749656&tp_key=d0dfe4e261 and via the investor relations section of the Company’s website here.

    A telephone replay of the call will be available approximately three hours after the call concludes and can be accessed through March 12, 2026, using the following information:

    Toll-free replay number:1-844-512-2921
    International replay number:1-412-317-6671
    Replay ID:13758224

    About Alliance Entertainment

    Alliance Entertainment (NASDAQ: AENT) is a premier distributor and fulfillment partner for the entertainment and pop culture collectibles industry. With more than 340,000 unique in-stock SKUs – including over 57,300 exclusive titles across compact discs, vinyl LPs, DVDs, Blu-rays, and video games – Alliance offers the largest selection of physical media in the market. Our vast catalog also includes licensed merchandise, toys, retro gaming products, and collectibles, serving over 35,000 retail locations and powering e-commerce fulfillment for leading retailers. Alliance also owns and operates proprietary collectibles brands, including Handmade by Robots™, a stylized vinyl figure line featuring licensed characters from leading entertainment franchises, and Alliance Authentic™, a premium platform for authentic, certified, and individually numbered entertainment collectibles. In addition, Alliance operates Endstate Authentic, a dedicated NFC-enabled authentication and digital product identity platform supporting authenticated collectibles, resale, and brand protection. Leveraging decades of operational expertise, exclusive sourcing relationships, and a capital-light, scalable infrastructure, Alliance connects fans and collectors to the products, franchises, and experiences they value across formats and generations. For more information, visit www.aent.com.

    For investor inquiries, please contact:

    Dave Gentry
    RedChip Companies, Inc.
    1-800-REDCHIP (733-2447)
    1-407-644-4256
    AENT@redchip.com

    Primary Logo

    Release – Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission

    Research News and Market Data on UNCY

    January 29, 2026 7:05am EST Download as PDF

    • DA assigns Prescription Drug User Fee Act (PDUFA) target date of June 27, 2026
    • Ended 2025 with unaudited cash position of $41.3M with expected runway into 2027

    LOS ALTOS, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the Company’s investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. The Agency has deemed the OLC resubmission to be a Class II complete response which has a six-month review period from the date of resubmission and set a Prescription Drug User Fee Act (PDUFA) target action date of June 27, 2026.

    “We are pleased that the agency has promptly accepted the resubmission of our NDA for OLC,” said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive. “We are advancing our commercial preparation activities in anticipation of a potential launch of OLC later this year, to help provide an important treatment option to patients with chronic kidney disease (CKD) on dialysis who continue to struggle with hyperphosphatemia.”

    The NDA is supported by data from three clinical studies (a Phase 1 study in healthy volunteers, a bioequivalence study in healthy volunteers and a tolerability study of OLC in CKD patients on dialysis), multiple preclinical studies as well as chemistry, manufacturing and controls (CMC) data. The FDA did not raise any concerns regarding OLC’s preclinical, clinical, or safety data included in the original NDA submission.

    The Company ended 2025 with an unaudited position of $41.3 million in cash, cash equivalents, and short-term investments, which permits continued advancement of OLC commercial launch activities and a cash runway into 2027.

    About Oxylanthanum Carbonate (OLC)
    OLC is an investigational oral phosphate binder that leverages proprietary nanoparticle technology to deliver high phosphate binding potency, reducing the number and size of pills that patients must take to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. Its potential best-in-class profile may have meaningful patient adherence benefits over currently available treatment options as it requires a lower pill burden.

    Unicycive is seeking FDA approval of OLC via the 505(b)(2) regulatory pathway. OLC is protected by a strong global patent portfolio including issued patents on composition of matter with exclusivity until 2031, and with the potential for patent term extension until 2035.

    About Hyperphosphatemia
    Hyperphosphatemia is a serious medical condition that occurs in nearly all patients with End Stage Renal Disease (ESRD). Annually there are over 450,000 individuals in the U.S. that require medication to control their phosphate levels.1 Uncontrolled hyperphosphatemia is strongly associated with increased death and hospitalization for CKD patients on dialysis. Treatment of hyperphosphatemia is aimed at lowering serum phosphate levels via two means: (1) restricting dietary phosphorus intake; and (2) using, on a daily basis, and with each meal, oral phosphate binding drugs that facilitate fecal elimination of dietary phosphate rather than its absorption from the gastrointestinal tract into the bloodstream.

    1Flythe JE. Dialysis-Past, Present, and Future: A Kidney360 Perspectives Series. Kidney360. 2023 May 1;4(5):567-568. doi: 10.34067/KID.0000000000000145.

    About Unicycive Therapeutics
    Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. For more information about Unicycive, visit Unicycive.com and follow us on LinkedIn and X.

    Forward-looking statements
    Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified using words such as “anticipate,” “believe,” “forecast,” “estimated” and “intend” or other similar terms or expressions that concern Unicycive’s expectations, strategy, plans or intentions. These forward-looking statements are based on Unicycive’s current expectations and actual results could differ materially. There are several factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, clinical trials involve a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future trial results; our clinical trials may be suspended or discontinued due to unexpected side effects or other safety risks that could preclude approval of our product candidates; risks related to business interruptions, which could seriously harm our financial condition and increase our costs and expenses; our need to raise substantial additional capital in the future to fund our continuing operations and the development and commercialization of our current product candidates and future product candidates; dependence on key personnel; substantial competition; uncertainties of patent protection and litigation; dependence upon third parties; risks related to delays in obtaining or failure to obtain FDA clearances or approvals and noncompliance with FDA regulations; and our failure, or the failure of our third-party manufacturers, or their subcontractors, to comply with cGMPs or other applicable regulations, which could result in sanctions being imposed on us or the manufacturers, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates, operating restrictions and criminal prosecutions, any of which could adversely affect supplies of our product candidates and harm our business and results of operations. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and other factors described more fully in the section entitled ‘Risk Factors’ in Unicycive’s Annual Report on Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Unicycive specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

    Investor Contacts:

    Kevin Gardner
    LifeSci Advisors
    kgardner@lifesciadvisors.com

    Media Contact:

    Layne Litsinger
    Real Chemistry
    llitsinger@realchemistry.com

    SOURCE: Unicycive Therapeutics, Inc.

    Primary Logo

    Source: Unicycive Therapeutics, Inc.

    Released January 29, 2026

    Release – 1-800-FLOWERS.COM, Inc. Reports Fiscal 2026 Second Quarter Results

    Research News and Market Data on FLWS

    Jan 29, 2026

    Reports Revenue of $702.2 million and Net Income of $70.6 million

    Generates Adjusted EBITDA1 of $98.1 million

    Provides Outlook for the Second Half of Fiscal Year 2026

    JERICHO, N.Y.–(BUSINESS WIRE)– 1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS), a leading provider of thoughtful expressions designed to help inspire customers to give more, connect more, and build more and better relationships, today reported results for its Fiscal 2026 second quarter ended December 28, 2025.

    “Our teams remained focused on executing against our key strategic priorities throughout the holiday period, which continues to reflect the early stages of our broader transformation,” said Adolfo Villagomez, Chief Executive Officer. “While the topline impact of our initiatives will take time as we address structural challenges within the business, we made solid progress in the second quarter on our cost-optimization and organizational-streamlining efforts, including meaningful steps toward transforming our structure into a more functional and efficient organization. These actions are strengthening our operating foundation and better positioning the Company to achieve sustainable, profitable growth. I am proud of how our teams supported our customers and advanced the operational improvements and strategic priorities that are essential to our long-term success.”

    Fiscal 2026 Second Quarter Performance

    • Total consolidated revenues decreased 9.5% to $702.2 million, compared with the prior year period, mainly due to a strategic shift that is focused on improving marketing effectiveness and profitability.
    • Gross profit margin decreased 120 basis points to 42.1%, compared with 43.3% in the prior year period, primarily due to deleveraging on the sales decline.
    • Operating expenses decreased $23.4 million to $221.1 million, compared with the prior year period, primarily due to lower marketing and labor costs. Excluding non-recurring charges and the impact of the Company’s non-qualified deferred compensation plan in both periods, operating expenses declined $25.9 million as compared with the prior year to $213.2 million.
    • Net income for the quarter was $70.6 million, or $1.10 per diluted share, as compared to a net income of $64.3 million, or $1.00 per share, in the prior year period.
    • Adjusted net income1 was $76.7 million, or $1.20 per diluted share, compared with an Adjusted Net income1 of $69.2 million, or $1.08 per share, in the prior year period.
    • Adjusted EBITDA1 for the quarter was $98.1 million, compared with Adjusted EBITDA1 of $116.3 million in the prior year period.

    (1) Refer to “Definitions of Non-GAAP Financial Measures” and the tables attached at the end of this press release for reconciliation of non-GAAP results to applicable GAAP results.

    Segment Results

    The Company provides Fiscal 2026 second quarter selected financial results for its Gourmet Foods & Gift Baskets, Consumer Floral & Gifts, and BloomNet® segments in the tables attached to this release and as follows:

    • Gourmet Foods & Gift Baskets: For the quarter, revenues declined 3.8% to $499.0 million, as compared with the prior year period. Gross profit margin decreased 120 basis points from the prior year period to 42.3% due to deleveraging on the sales decline and increased tariff, commodity and shipping costs. The segment contribution margin1 was $105.3 million, compared with segment contribution margin of $111.4 million in the prior year period, excluding severance and system implementation costs.
    • Consumer Floral & Gifts: For the quarter, revenues declined 22.7% to $181.2 million, as compared with the prior year period. Gross profit margin decreased 180 basis points from the prior year period to 40.1% due to deleveraging on the sales decline, as well as higher tariff and commodity costs. The segment contribution margin1 was $16.6 million, compared with $21.6 million in the prior year period, excluding severance costs.
    • BloomNet: For the quarter, revenues decreased 3.1% to $22.1 million, as compared with the prior year period. Gross profit margin remained consistent with the prior year period at 50.9%. The segment contribution margin1 was $6.4 million, compared with $7.5 million in the prior year period, excluding severance costs.

    Fiscal Year 2026 Outlook

    The Company views Fiscal Year 2026 as a pivotal period of foundation setting. By transforming 1-800-Flowers.com, Inc. into a customer-centric, data-driven organization with clear objectives and ROI-focused decision making, the Company aims to position itself to fuel future growth.

    For the second half of Fiscal Year 2026, the Company expects revenue to decline in the low double-digit range, reflecting a continued focus on improving marketing contribution margin, the impact of changes to search engine results page, including increased paid placements and AI-driven content, which negatively impacted organic visibility and direct traffic, and tougher comparisons following higher levels of less efficient marketing spend in the prior year.

    For the second half of Fiscal Year 2026, the Company expects Adjusted EBITDA1 to decline slightly compared to the prior year. On a normalized basis for the second half of Fiscal Year 2026, Adjusted EBITDA1 is expected to increase slightly year over year, which excludes approximately $12 million of anticipated incentive compensation and consultant costs incurred in the period. Ongoing cost-optimization initiatives and organizational-streamlining efforts are expected to help offset topline pressure.

    The Company’s strategic priorities are focused on positioning the organization for long-term growth. These priorities include:

    • driving cost savings and organizational efficiency,
    • building a customer-centric and data-driven organization,
    • broadening our reach beyond our e-commerce sites into new channels, and
    • strengthening our team through enhanced talent and accountability.

    With a renewed commitment to agility and customer-centricity, the Company believes these foundational steps will set the stage for sustainable revenue and profit growth in the years to come.

    Conference Call

    The Company will conduct a conference call to discuss its financial results today, January 29, 2026, at 8:00 a.m. (ET). The conference call will be webcast from the Investors section of the Company’s website at www.1800flowersinc.com. A recording of the call will be posted on the Investors section of the Company’s website within two hours of the call’s completion.

    Definitions of non-GAAP Financial Measures:

    We sometimes use financial measures derived from consolidated financial information, but not presented in our financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Certain of these are considered “non-GAAP financial measures” under the U.S. Securities and Exchange Commission rules. Non-GAAP financial measures referred to in this document are either labeled as “non-GAAP,” “adjusted” or designated as such with a “1”. See below for definitions and the reasons why we use these non-GAAP financial measures. Where applicable, see the Selected Financial Information below for reconciliations of these non-GAAP measures to their most directly comparable GAAP financial measures. Reconciliations for forward-looking figures would require unreasonable efforts at this time because of the uncertainty and variability of the nature and amount of certain components of various necessary GAAP components, including, for example, those related to compensation, tax items, amortization or others that may arise during the year, and the Company’s management believes such reconciliations would imply a degree of precision that would be confusing or misleading to investors. For the same reasons, the Company is unable to address the probable significance of the unavailable information. The lack of such reconciling information should be considered when assessing the impact of such disclosures.

    EBITDA and Adjusted EBITDA:

    We define EBITDA as net income (loss) before interest, taxes, depreciation, and amortization. Adjusted EBITDA is defined as EBITDA adjusted for the impact of stock-based compensation, Non-Qualified Deferred Compensation Plan (“NQDC”) investment appreciation/depreciation, and for certain items affecting period-to-period comparability. See Selected Financial Information for details on how EBITDA and Adjusted EBITDA were calculated for each period presented. The Company presents EBITDA and Adjusted EBITDA because it considers such information meaningful supplemental measures of its performance and believes such information is frequently used by the investment community in the evaluation of similarly situated companies. The Company uses EBITDA and Adjusted EBITDA as factors to determine the total amount of incentive compensation available to be awarded to executive officers and other employees. The Company’s credit agreement uses EBITDA and Adjusted EBITDA-related items to determine its interest rate and to measure compliance with certain covenants. EBITDA and Adjusted EBITDA are also used by the Company to evaluate and price potential acquisition candidates. EBITDA and Adjusted EBITDA have limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of the Company’s results as reported under GAAP. Some of the limitations are: (a) EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, the Company’s working capital needs; (b) EBITDA and Adjusted EBITDA do not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on the Company’s debts; and (c) although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future and EBITDA does not reflect any cash requirements for such capital expenditures. EBITDA and Adjusted EBITDA should only be used on a supplemental basis combined with GAAP results when evaluating the Company’s performance.

    Segment Contribution Margin and Adjusted Segment Contribution Margin:

    We define Segment Contribution Margin as earnings before interest, taxes, depreciation, and amortization, before the allocation of corporate overhead expenses. Adjusted Segment Contribution Margin is defined as Segment Contribution Margin adjusted for certain items affecting period-to-period comparability. See Selected Financial Information for details on how Segment Contribution Margin and Adjusted Segment Contribution Margin were calculated for each period presented. When viewed together with our GAAP results, we believe Segment Contribution Margin and Adjusted Segment Contribution Margin provide management and users of the financial statements meaningful information about the performance of our business segments. Segment Contribution Margin and Adjusted Segment Contribution Margin are used in addition to and in conjunction with results presented in accordance with GAAP and should not be relied upon to the exclusion of GAAP financial measures. The material limitation associated with the use of Segment Contribution Margin and Adjusted Segment Contribution Margin is that they are an incomplete measure of profitability as they do not include all operating expenses or non-operating income and expenses. Management compensates for this limitation when using these measures by looking at other GAAP measures, such as Operating Income and Net Income.

    Adjusted Net Income (Loss) and Adjusted or Comparable Net Income (Loss) Per Common Share:

    We define Adjusted Net Income (Loss) and Adjusted or Comparable Net Income (Loss) Per Common Share as Net Income (Loss) and Net Income (Loss) Per Common Share adjusted for certain items affecting period-to-period comparability. See Selected Financial Information below for details on how Adjusted Net Income (Loss) Per Common Share and Adjusted or Comparable Net Income (Loss) Per Common Share were calculated for each period presented. We believe that Adjusted Net Income (Loss) and Adjusted or Comparable Net Income (Loss) Per Common Share are meaningful measures because they increase the comparability of period-to-period results. Since these are not measures of performance calculated in accordance with GAAP, they should not be considered in isolation of, or as a substitute for, GAAP Net Income (Loss) and Net Income (Loss) Per Common Share, as indicators of operating performance and they may not be comparable to similarly titled measures employed by other companies.

    Free Cash Flow:

    We define Free Cash Flow as net cash provided by (used in) operating activities less capital expenditures. The Company considers Free Cash Flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by the business after the purchases of fixed assets, which can then be used to, among other things, invest in the Company’s business, make strategic acquisitions, strengthen the balance sheet, and repurchase stock or retire debt. Free Cash Flow is a liquidity measure that is frequently used by the investment community in the evaluation of similarly situated companies. Since Free Cash Flow is not a measure of performance calculated in accordance with GAAP, it should not be considered in isolation or as a substitute for analysis of the Company’s results as reported under GAAP. A limitation of the utility of Free Cash Flow as a measure of financial performance is that it does not represent the total increase or decrease in the Company’s cash balance for the period.

    About 1-800-FLOWERS.COM, Inc.

    1-800-FLOWERS.COM, Inc. is a leading provider of thoughtful expressions designed to help inspire customers to share more, connect more, and build more and better relationships. The Company’s e-commerce business platform features an all-star family of brands, including: 1-800-Flowers.com®, 1-800-Baskets.com®, Card Isle®, Cheryl’s Cookies®, Harry & David®, PersonalizationMall.com®, Shari’s Berries®, FruitBouquets.com®, Things Remembered®, Moose Munch®, The Popcorn Factory®, Wolferman’s Bakery®, Vital Choice®, Simply Chocolate® and Scharffen Berger®. Through the Celebrations Passport® loyalty program, which provides members with free standard shipping and no service charge on eligible products across our portfolio of brands, 1-800-FLOWERS.COM, Inc. strives to deepen relationships with customers. The Company also operates BloomNet®, an international floral and gift industry service provider offering a broad-range of products and services designed to help members grow their businesses profitably; Napco℠, a resource for floral gifts and seasonal décor; and DesignPac®, a manufacturer of gift baskets and towers. 1-800-FLOWERS.COM, Inc. was recognized among America’s Most Trustworthy Companies by Newsweek for 2024. 1-800-FLOWERS.COM, Inc. was also recognized as one of America’s Most Admired Workplaces for 2025 by Newsweek and was named to the Fortune 1000 list in 2022. Shares in 1-800-FLOWERS.COM, Inc. are traded on the NASDAQ Global Select Market, ticker symbol: FLWS. For more information, visit 1800flowersinc.com.

    FLWS-COMP
    FLWS-FN

    Special Note Regarding Forward Looking Statements:

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent the Company’s current expectations or forecasts concerning future events; they do not relate strictly to historical or current facts. Such statements can generally be identified by words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “foresee,” “forecast,” “likely,” “should,” “will,” “target,” or similar words or phrases. These forward-looking statements are subject to risks, uncertainties, and other factors, many of which are outside of the Company’s control, which could cause actual results to differ materially from the results expressed or implied in the forward-looking statements, including, but not limited to, statements relating to future actions; the Company’s ability to leverage its operating platform and reduce its operating expense ratio; its ability to successfully integrate acquired businesses and assets; its ability to successfully execute its strategic priorities; its ability to cost effectively acquire and retain customers and drive purchase frequency; the outcome of contingencies, including legal proceedings in the normal course of business; its ability to compete against existing and new competitors; its ability to manage expenses associated with sales and marketing and necessary general and administrative and technology investments; its ability to reduce promotional activities and achieve more efficient marketing programs; and general consumer sentiment and industry and economic conditions that may affect levels of discretionary customer purchases of the Company’s products. The Company cannot guarantee that any forward-looking statement will be realized. Achievement of future results is subject to risk, uncertainties and potentially inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements. The Company undertakes no obligation to publicly update any of the forward-looking statements, whether because of new information, future events or otherwise, made in this release or in any of its SEC filings. Consequently, you should not consider any such list to be a complete set of all potential risks and uncertainties. For a more detailed description of these and other risk factors, refer to the Company’s SEC filings, including the Company’s Annual Reports on Form 10-K and its Quarterly Reports on Form 10-Q.

    View the full release here.

    Investor Contact:

    Andy Milevoj

    investors@1800flowers.com

    Media Contact:

    press@1800flowers.com

    Source: 1-800-FLOWERS.COM, Inc.

    Great Lakes Dredge & Dock (GLDD) – Updated Model; Raising Price Target


    Thursday, January 29, 2026

    Great Lakes Dredge & Dock Corporation is the largest provider of dredging services in the United States. In addition, Great Lakes is fully engaged in expanding its core business into the rapidly developing offshore wind energy industry. The Company has a long history of performing significant international projects. The Company employs experienced civil, ocean and mechanical engineering staff in its estimating, production and project management functions. In its over 131-year history, the Company has never failed to complete a marine project. Great Lakes owns and operates the largest and most diverse fleet in the U.S. dredging industry, comprised of approximately 200 specialized vessels. Great Lakes has a disciplined training program for engineers that ensures experienced-based performance as they advance through Company operations. The Company’s Incident-and Injury-Free® (IIF®) safety management program is integrated into all aspects of the Company’s culture. The Company’s commitment to the IIF® culture promotes a work environment where employee safety is paramount.

    Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

    Refer to the full report for the price target, fundamental analysis, and rating.

    Updated Model. We tweaked our 4Q25 projections to include higher expected interest expense and the projected $3 million charge related to the payoff of the second lien term loan. As a result, our 4Q25 EPS estimate drops to $0.22 from a prior $0.26. The drop is not related to operational performance, and the debt swap will reduce overall interest expense going forward.

    Cash Flow. With the completion of the new build program in early 2026, we expect Great Lakes to use the substantial free cash flow generation towards debt reduction. Over the past 5 years, capex has averaged $136 million annually. Roughly $25 million is for maintenance capex, and we do expect some additional capex as Great Lakes modernizes its fleet. Nonetheless, we estimate there should be at least $90 million on an annual basis for debt reduction.


    Get the Full Report

    Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

    This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

    *Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

    Hemisphere Energy (HMENF) – 2026 Corporate Guidance Released, Revising Estimates


    Thursday, January 29, 2026

    Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

    Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

    Refer to the full report for the price target, fundamental analysis, and rating.

    Outlook for 2026. Hemisphere Energy released 2026 guidance outlining a C$12.0 million capital program, expected to support ~6.3% growth in average annual production to approximately 3,900 boe/d, compared to our estimated 2025 average of 3,670 boe/d. The capital program is expected to be fully funded from adjusted funds flow and is designed to provide disciplined year-over-year growth while protecting the balance sheet and maintaining shareholder returns. Production is expected to remain 99% heavy oil, supported primarily by polymer flood enhanced oil recovery at Atlee Buffalo.

    Updating estimates. We are trimming our 2026 revenue estimate to C$89.9 million from C$93.7 million due to lower production and commodity price estimates. Our production and WTI crude oil price estimates are now 3,900 boe/d and US$60 compared to our previous estimates of 4,080 boe/d and US$65. Despite the lower revenue outlook, adjusted funds flow (AFF) increased modestly to C$40.0 million from C$39.7 million, reflecting lower assumed operating costs, improved differentials, and a reduced royalty burden. AFF per share remains unchanged at C$0.40.


    Get the Full Report

    Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

    This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

    *Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

    Alliance Resource Partners (ARLP) – Upcoming FY 2025 Financial Results and 2026 Corporate Guidance


    Thursday, January 29, 2026

    ARLP is a diversified natural resource company that generates operating and royalty income from coal produced by its mining complexes and royalty income from mineral interests it owns in strategic oil & gas producing regions in the United States, primarily the Permian, Anadarko and Williston basins. ARLP currently produces coal from seven mining complexes its subsidiaries operate in Illinois, Indiana, Kentucky, Maryland and West Virginia. ARLP also operates a coal loading terminal on the Ohio River at Mount Vernon, Indiana. ARLP markets its coal production to major domestic and international utilities and industrial users and is currently the second largest coal producer in the eastern United States. In addition, ARLP is positioning itself as an energy provider for the future by leveraging its core technology and operating competencies to make strategic investments in the fast growing energy and infrastructure transition.

    Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

    Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

    Refer to the full report for the price target, fundamental analysis, and rating.

    Fourth quarter and full year 2025 financial results. Alliance will report its fourth quarter and full year 2025 financial results before the market opens on Monday, February 2, 2026. Management will host an investor conference call and webcast the same day at 10:00 am ET. Along with the 2025 operational and financial results, we expect ARLP to release its 2026 corporate guidance and outlook.

    Noble Estimates. We forecast fourth quarter 2025 revenue, EBITDA, and EPU of $560.1 million, $182.9 million, and $0.57, respectively. Our full year 2025 revenue, EBITDA, and EPU estimates are $2.2 billion, $690.5 million, and $2.33, respectively. Our fourth quarter EPU estimate reflects an expected unrealized and non-cash loss on the marked-to-market value of ARLP’s bitcoin holdings, which has no impact on our EBITDA estimate. We forecast 2026 revenue, EBITDA, and EPU of $2.3 billion, $700.5 million, and $2.65, respectively.


    Get the Full Report

    Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

    This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

    *Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

    Release – Townsquare Announces Conference Call to Discuss Fourth Quarter 2025 Results and Participation in Upcoming Emerging Growth Conference

    Research News and Market Data on TSQ

    Jan 28, 2026 

    Purchase, NY – January 28, 2026 – Townsquare Media, Inc. (NYSE: TSQ) (“Townsquare” or the “Company”) announced today details related to its conference call to discuss fourth quarter financial results as well as Townsquare’s participation in an upcoming investor conference.

    Fourth Quarter 2025 Conference Call

    The Company will release fourth quarter 2025 financial results before the market opens on Monday, March 16, 2026. The Company will host a conference call to discuss certain fourth quarter 2025 financial results on Monday, March 16, 2026 at 8:00 a.m. Eastern Time.

    The conference call dial-in number is 1-800-717-1738 (U.S. & Canada) or 1-646-307-1865 (International) and the conference ID is “Townsquare.” A live webcast of the conference call as well as the press release disclosing the Company’s results will be available on the investor relations page of the Company’s website at www.townsquaremedia.com.

    A telephone replay of the conference call will be available through March 23, 2026. To access the replay, please dial 1-844-512-2921 (U.S. & Canada) or 1-412-317-6671 (International) and enter confirmation code 1134751. A web-based archive of the conference call will also be available on the investor relations page of the Company’s website.

    Noble Capital Markets’ Emerging Growth Virtual Equity Conference

    Management will present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference on Wednesday, February 4, 2026. The presentation will be held at 10:30 AM Eastern Time and will feature a fireside style Q&A session with questions welcome from the live virtual audience. Scheduled 1×1 meetings with management are also available for registered, qualified investor attendees.

    Attendees interested in viewing the live presentation can register for this event, at no cost, here: Virtual Equity Conference Registration.

    Qualified investors wishing to meet 1×1 with management can reach out to Giorgia Pigato, from Noble Capital Markets, at gpigato@noblecapitalmarkets.com.

    A video webcast of the presentation will be available following the event on the investor relations page of Townsquare’s website at www.townsquaremedia.com, and as part of a complete catalog of presentations available on Channelchek, www.channelchek.com, the investor portal created by Noble. The webcast will be archived on the Company’s website and on Channelchek.com for 90 days following the event.

    About Townsquare Media, Inc.

    Townsquare is a community-focused digital and broadcast media and digital marketing solutions company principally focused outside the top 50 markets in the U.S. Townsquare Ignite, our robust digital advertising division, specializes in helping businesses of all sizes connect with their target audience through data-driven, results based strategies, by utilizing a) our proprietary digital programmatic advertising technology stack with an in-house demand and data management platform and b) our owned and operated portfolio of more than 400 local news and entertainment websites and mobile apps along with a network of leading national music and entertainment brands, collecting valuable first party data. Townsquare Interactive, our subscription digital marketing services business, partners with SMBs to help manage their digital presence by providing a SAAS business management platform, website design, creation and hosting, search engine optimization and other digital services. And through our portfolio of local radio stations strategically situated outside the Top 50 markets in the United States, we provide effective advertising solutions for our clients and relevant local content for our audiences. For more information, please visitwww.townsquaremedia.comwww.townsquareinteractive.com, and www.townsquareignite.com.

    About Noble Capital Markets

    Established in 1984, Noble Capital Markets is an SEC / FINRA registered full-service investment bank and advisory firm with an award-winning research team and proprietary investor distribution platform. We deliver middle market expertise to entrepreneurs, corporations, financial sponsors, and investors. Over the past 40 years, Noble has raised billions of dollars for companies and published more than 45,000 equity research reports.

    About Channelchek

    Noble launched www.channelchek.com in 2018 – an investor community dedicated exclusively to public emerging growth companies and their industries. Channelchek is the first service to offer institutional-quality research to the public, for FREE at every level without a subscription. More than 7,000 public emerging growth companies are listed on the site, and content including equity research, webcasts, and industry articles.

    Investor Relations:
    Claire Yenicay
    (203) 900-5555
    investors@townsquaremedia.com

    Release – Resources Connection, Inc. Announces Quarterly Dividend and Dividend Payment Date

    RGP global consulting and project execution for business transformation

    Research News and Market Data on RGP

    DALLAS–(BUSINESS WIRE)–Jan. 28, 2026–
    Resources Connection, Inc. (Nasdaq: RGP) (the “Company”) announced today that the Board of Directors has approved a cash dividend of $0.07 per share, payable on March 20, 2026 to all stockholders of record on February 20, 2026.

    ABOUT RGP

    RGP (Nasdaq: RGP) is an award-winning global professional services firm with three decades of experience helping the world’s top organizations navigate change and seize opportunity. With three integrated offerings—On-Demand Talent, Consulting, and Outsourced Services—we provide CFOs and other C-suite leaders with the flexibility to solve today’s most pressing challenges on their terms, uniting strategy, execution, and talent across accounting and finance, digital transformation, data, and cloud, at global scale. Our people-first approach continues to drive innovation across industries worldwide.

    Based in Dallas, TX with offices worldwide, we annually engage with over 1,500 clients around the world from 40 physical practice offices and multiple virtual offices. As of January 2026, RGP is proud to have served 90% of the Fortune 100 and has been recognized by U.S. News & World Report (2024-2025 Best Companies to Work for) and Forbes (America’s Best Management Consulting Firms 2025, America’s Best Midsize Employers 2025, World’s Best Management Consulting Firms 2024).

    The Company is listed on the Nasdaq Global Select Market, the exchange’s highest tier by listing standards. To learn more about RGP, visit: http://www.rgp.com. (RGP-F)

    Investor Contact:
    Jennifer Ryu, Chief Financial Officer

    (US+) 1-714-430-6500

    jennifer.ryu@rgp.com

    Media Contact:
    Pat Burek
    Financial Profiles

    (US+) 1-310-622-8244

    pburek@finprofiles.com

    Source: Resources Connection, Inc.

    Release – Alliance Resource Partners, L.P. Declares Quarterly Distribution of $0.60 Per Unit

    Research News and Market Data on ARLP

    TULSA, Okla.–(BUSINESS WIRE)–Alliance Resource Partners, L.P. (NASDAQ: ARLP) today announced that the Board of Directors of ARLP’s general partner approved a cash distribution to its unitholders for the quarter ended December 31, 2025 (the “2025 Quarter”).

    ARLP unitholders of record as of the close of trading on February 6, 2026 will receive a cash distribution for the 2025 Quarter of $0.60 per unit (an annualized rate of $2.40 per unit), payable on February 13, 2026. The announced distribution is consistent with the cash distribution of $0.60 per unit for the quarter ended September 30, 2025.

    As previously announced, ARLP will report financial results for the 2025 Quarter before the market opens on Monday, February 2, 2026 and Alliance management will discuss these results during a conference call beginning at 10:00 a.m. Eastern that same day.

    To participate in the conference call, dial (877) 407-0784 and request to be connected to the Alliance Resource Partners, L.P. earnings conference call. International callers should dial (201) 689-8560 and request to be connected to the same call. Investors may also listen to the call via the “Investors” section of ARLP’s website at www.arlp.com.

    An audio replay of the conference call will be available for approximately one week. To access the audio replay, dial U.S. Toll Free (844) 512-2921; International Toll (412) 317-6671 and request to be connected to replay using access code 13757920.

    Concurrent with this announcement we are providing qualified notice to brokers and nominees that hold ARLP units on behalf of non-U.S. investors under Treasury Regulation Section 1.1446-4(b) and (d) and Treasury Regulation Section 1.1446(f)-4(c)(2)(iii). Brokers and nominees should treat one hundred percent (100%) of ARLP’s distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. In addition, brokers and nominees should treat one hundred percent (100%) of the distribution as being in excess of cumulative net income for purposes of determining the amount to withhold. Accordingly, ARLP’s distributions to non-U.S. investors are subject to federal income tax withholding at a rate equal to the highest applicable effective tax rate plus ten percent (10%). Nominees, and not ARLP, are treated as the withholding agents responsible for withholding on the distributions received by them on behalf of non-U.S. investors.

    About Alliance Resource Partners, L.P.

    ARLP is a diversified energy company that is currently the second largest coal producer in the eastern United States, supplying reliable, affordable energy domestically and internationally to major utilities, metallurgical and industrial users. ARLP also generates operating and royalty income from mineral interests it owns in strategic coal and oil & gas producing regions in the United States. In addition, ARLP is evolving and positioning itself as a reliable energy partner for the future by pursuing opportunities that support the growth and development of energy and related infrastructure.

    News, unit prices and additional information about ARLP, including filings with the Securities and Exchange Commission (“SEC”), are available at www.arlp.com. For more information, contact the investor relations department of ARLP at (918) 295-7673 or via e-mail at investorrelations@arlp.com.

    Contacts

    Investor Relations Contact

    Cary P. Marshall
    Senior Vice President and Chief Financial Officer
    918-295-7673
    investorrelations@arlp.com